Dexamethasone and Insulin Affecting SFTPA1 and SFTPA2 mRNA Levels

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Informatics. Official publication website can be found on muni.cz.
Authors

RUČKA Zdeněk TESAŘOVÁ Lenka POTĚŠILOVÁ Michaela STEJSKAL Stanislav KRONTORÁD KOUTNÁ Irena VAŇHARA Petr DOLEŽEL Jan

Year of publication 2010
Type Article in Proceedings
Conference Advances in Molecular and Cancer Biology, 2010
MU Faculty or unit

Faculty of Informatics

Citation
Field Genetics and molecular biology
Keywords Lung surfactant; Insulin; Dexamethasone
Description Lung surfactants primary function is to lower surface tension and therefore it protects alveoli from collapsing. It consists of phospholipids and four proteins. These proteins stabilize the surfactant layer (SFTPB and SFTPC) and modulate immunological response to various pathogens (SFTPA, SFTPD), which is the secondary role of lung surfactant. Low levels of surfactant proteins lead to severe diseases. Dexamethasone and insulin were applied on H441 cell line. This cell line resembles Clara cells and therefore serves as a model of lung surfactant producing cells. SFTPA1 (and its analog SFTPA2) were not affected by insulin (2500 ng/mL), but dexamethasone treatment (10-7 M) for 48 hours resulted in 50% decrease in their mRNA production. Surprisingly, combination of dexamethasone and insulin resulted in 90% decrease.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info